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Serum protein halogenation and nitrosylation: 
trait of maintained overstimulation of blood 
phagocytes in sporadic Parkinson’s diseaseE Fernández*
Abstract
IntroductionHalogenative and nitrosative stress are two types of oxidative stress that have been proposed as pathogenic mechanisms in Parkinson’s disease (PD). They can be caused by over-stimulation of phagocytes. This hyp-
othesis discusses serum protein hal-
ogenation and nitrosylation as traits 
of maintained overstimulation of 
blood phagocytes in sporadic 
Parkinson’s disease.
HypothesisI hypothesize that maintained phago-cyte overstimulation leads to both halogenative and nitrosative stress in PD, which are present in the serum 
and cerebrospinal fluid of patients. These types of oxidative stress could modify proteins related to the pathogenesis of PD.
Evaluation of hypothesis
It has been detected that the presen-ce of halogenative stress in the seru-m and, to a lesser extent, cerebro-
spinal fluid of Parkinsonian patients leads to excess of advanced oxidized protein products. On the other hand, nitrosative stress is also present in serum and cerebrospinal fluid of pat-
ients with early PD, characterized by the selective increase of 3-nitrotyro-sine proteins other than nitroalbum-in and free 3-nitrotyrosine. Nitrosyl-ation stress accompanies modificati-
on of the sites of nitrosylation of α-
synuclein in these patients, charact-erized by dominant  nitrosylation of  tyrosine 125/136  residues. 
ConclusionSince metabolism of advanced oxidized protein products and 3- nitrotyrosine proteins has been as-sociated with phagocytic overstimu-lation, this pathological alteration could play a pathogenic role in spo-radic PD. Our observations also lead to the hypothesis that serum level of advanced oxidized protein products is a  prognostic marker for PD dura-tion, and these oxidized proteins 
could participate in neuroinflam-mation. Besides, the evaluation of nitrosative stress through enhanced levels of 3-nitrotyrosine proteins 
in serum and cerebrospinal fluid without changes in nitroalbumin, 
together with the profile of tyrosine 
nitrosylation of serum α-synuclein characterized by dominant nitrosyl-ation of Tyr125/136, could serve for the diagnosis of sporadic PD. Nitro-
α-synuclein is a main component of Lewy bodies, hallmarks of the  disease, and serum nitro-α-synuclein could represent a pathogenic factor in PD.
Introduction
Oxidative stress is defined as an im-balance between the production of reactive oxygen and nitrogen spe-cies (ROS/RNS) and antioxidant mechanisms, and it is considered as an important pathogenic mecha-nism in Parkinson’s disease (PD)1–4. Halogenation is a type of oxidative stress induced by phagocytic over-stimulation, leading to excess of several molecules such as advanced oxidized protein products (AOPPs). These products originate as a result of the action of free radicals such as chloramines and  hypochlorous 
acid (HOCl) on proteins, and they are augmented in several diseases5. This halogenative process could also modify free amines such as  tyrosine, leading to the formation of free 3- chlorotyrosine, as shown in  Figure 1. Another type of oxidative stress is nitrosylation, where oxidative modi-
fications of proteins are secondary to excess of nitric oxide. Nitrosylation of tyrosine leading to 3-nitrotyros-ine proteins or free 3-nitrotyrosine is the most prominent change, and this type of oxidative stress has been associated with human pathologies6, and it is recognized as a salient fea-
ture of diverse α-synucleinopathies such as PD and Lewy body dementia7. In PD, protein tyrosine nitrosylation has been demonstrated to represent a pathogenic mechanism, and nitros-ylated tyrosine residues of diverse 
proteins such as neurofilaments or 
α-synuclein are detected in the brain proteinaceous aggregates or Lewy bodies, hallmarks of the disease8. Moreover, nitrating agents generated by dopamine are known to promote 
α-synuclein aggregation9, a critical step for the formation of Lewy bodies. Biochemically,  nitrosylated proteins and amines can be formed through different pathways  (Figure 1). The formation of peroxynitrite (ONOO–) through nitric oxide and superoxide anion is the main pathway10. How-ever, other nitrating pathways re-lated to phagocyte overstimulation exist. For instance, myeloperoxidase (MPO) activity and nitric oxide ex-cess from macrophages or brain mi-croglia yield nitrosylated proteins and nitrotyrosines11. This hypoth-esis discusses if protein  halogenation 
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 presence of 3-chlorotyrosine was evaluated in the serum and CSF from PD patients with mass spectrometry. 3- Chlorotyrosine was not detected 
in any fluid. To  further analyse AOPP properties, simple linear regression analyses between AOPP levels and clinical characteristics were carried out. In PD patients, serum AOPP lev-els found to be related to Hoehn–Yahr stage and to levodopa dosage. The higher Hoehn–Yahr stage or levodo-pa dose, the lower serum AOPP lev-els. Besides, considering individual duration of disease and AOPP levels 
in stage 2/3 patients, a significant regression was observed between patients and serum AOPP levels12. It seems that serum AOPP levels pre-dict how large the disease is in this group of patients.Second, the presence of nitro-sative stress in the blood and CSF of PD patients was evaluated through ELISA of 3-nitrotyrosine proteins.  Serum 3-nitrotyrosine protein levels 
were significantly enhanced in ear-ly-PD patients (Hoehn–Yahr stages 1 and 2). Interestingly, other mark-ers of nitrosylation such as serum  nitroalbumin or free 3-nitrotyros-ine were not affected. On the other hand, CSF 3-nitrotyrosine protein levels were also enhanced in patients and, taking into account Hoehn–Yahr  stages, this effect was detected in  early-PD patients again. Besides, neither nitroalbumin nor free 3-ni-trotyrosine was affected in CSF of 
patients. These findings suggested that nitrosylation was quite selec-tive, and I decided to discern which proteins are affected by nitrosylation stress. By means of western blotting 
and one-step filtered serum (Amicon 
50K filters), a 3-nitrotyrosine pro-tein band of approx. 56 kDa in serum from patients and controls was de-tected, corresponding to 3-nitroty-
rosine α-synuclein, because the same signal was detected after both anti-
3-nitrotyrosine and anti-α-synuclein antibodies. A approx. 56 kDa band is characteristic of tetrameric 
Figure 1: Main metabolic pathways of halogenative and nitrosative stress related to phagocyte overstimulation. Halogenated proteins or AOPPs, and free 3- and di-chlorotyrosines, originate as a result of the action of free radicals such as chloramines and hypochlorous acid (HOCl). These radicals are formed from hydrogen peroxide (H2O2) due to the release of superoxide anion (O2−) from phagocytes and the action of superoxide dismutase. Nitrosative stress leading to nitrosylated proteins and nitrotyrosines is caused by two main pathways. First, peroxynitrite (ONOO–) is formed through nitric oxide (NO) and superoxide anion released by phagocytes. Second, MPO activity from phagocytes yields hypochlorous acid that reacts with nitrogen dioxide (NO2–) derived from nitric oxide and superoxide anion, and nitryl chloride (NO2Cl) is formed. Both peroxynitrite and nitryl chloride can induce the formation of 3-nitrotyrosine proteins and free nitrotyrosines. NADPH, nicotinamide adenine dinucleotide phosphate; MPO, myeloperoxidase; SOD, superoxide dismutase; H+, hydrogen; AOPP, advanced oxidized protein products.and  nitrosylation are caused by  overstimulation of phagocytes in PD. 
HypothesisI hypothesize that both halogenative and nitrosative stress are present in 
serum and cerebrospinal fluid (CSF) of PD patients, and both types of oxi-dative stress would modify proteins which could be related to the patho-genesis of PD12,13.
Evaluation of hypothesisInformed consent forms under a protocol approved by the Univer-sity of Seville and Macarena Hospital  
internal ethics and scientific boards 
were obtained from all the subjects, and the subjects’ consent was ob-tained according to the Declaration of  Helsinki (BMJ 1991;302:1194). 
First, AOPP levels were quantified through ELISA, and they were found to be higher in serum and CSF of PD patients relative to control, but only 
serum AOPP values were signifi-cantly different. Taking into account Hoehn–Yahr stages of the disease, AOPP levels were progressively re-duced in serum, and levels in ad-vanced or Hoehn–Yahr stage 3 and 4 patients are similar to controls. Since halogenative oxidation can also yield halogenated amines, the 
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α-synuclein, the physiological form 
of endogenous α-synuclein14. When 
levels of total α-synuclein in serum through ELISA were measured, no differences were found. Regarding 
CSF, α-synuclein levels were found to 
be significantly lower in patients rel-ative to controls, as already reported by others15, but a nitrosylated band of approx. 56 kDa was not detected. 
Hence α-synuclein is present in CSF of patients with PD at lower values than normal, but it seems not to be nitrosylated13.
Consequence of hypothesisTo further characterize the effects of 
nitrosative stress on serum nitro-α-
synuclein (N-αSyn), and taking into account that tyrosine residues of 
N-αSyn can be differentially nitros-ylated leading to different functional effects16–21, the sites of tyrosine nitros-ylation of the molecule were evalu-ated. Changes in the nitrosylation of tyrosine residues located at the car-boxyl-terminus of the molecule (ty-rosines at sites 125/136) and at the amine-terminus (tyrosine residue at position 39) were observed. Thus in-tensity of nitrosylation at Tyr125/136 sites was enhanced in Hoehn–Yahr stage 1 and 2 patients, and nitrosyla-tion of the tyrosine 39 site was found to be reduced in stage 1 patients rela-tive to controls. Representative blot bands of nitrosylation at Tyr125/136 
residues of N-αSyn on early stage 1 patients are shown in Figure 2. On 
measuring the ratio defined as the in-
tensity of N-αSyn-Tyr125/136 band 
between intensity of N-αSyn-Tyr39 
band, it was found to be significantly elevated in patients with early PD ver-sus advanced patients and controls, as summarized in Table 1. Thus all pa-tients at Hoehn–Yahr stage 1, and 90% of patients at stage 2 showed a ratio higher than 1.6, while this ratio was ever observed to be lower than 1.6 in control subjects and advanced pa-tients. This value could be  considered as a limit between  patients with early PD and controls13.
Figure 2: Representative blot bands of patients with early Parkinson’s disease 
(Hoehn–Yahr stage 1 group) and controls, after N-αSyn Tyr125/136 monoclonal antibody. The intensity of blot bands is observed to be enhanced in patients. 
N-αSyn Tyr125/136, nitrosylated αSyn with nitrosylation of tyrosine residues 125/136.
Table 1 Ratio of intensity of N-αSyn-Tyr125/136 blot band between intensity 
of N-αSyn-Tyr39 band in early and advanced patients with Parkinson’s disease 
(PD) and controls
Controls Early PD Advanced PD
Ratio (mean ± SEM) 0.95 ± 0.1 3.2 ± 0.4** 0.92 ± 0.2
** P < 0.01 versus controls and advanced patients (Student’s t test)
DiscussionOur studies show that there are in-dicators of halogenative oxidation stress in serum and, to a lesser extent, 
cerebrospinal fluid of PD, character-ized by enhanced levels of AOPPs without changes in free 3-chloro-
tyrosine. The findings also indicate that serum and CSF AOPP levels are progressively reduced over time, and levodopa treatment contributes to these changes.Metabolism of AOPPs has been associated to several diseases previ-ously5, where blood phagocytes are overstimulated and the formation of HOCl and chloramines from chloride and released hydrogen peroxide is enhanced. MPO catalyses this pro-cess and, as a consequence, AOPP are formed due to oxidative stress. Since AOPPs can conjugate with human se-roalbumin (HSA) giving AOPP-HSA 
conjugates, inflammatory mediators, it can be hypothesized that AOPPs 
could be linked to neuroinflamma-tion, a process whose pathogenic role in PD is widely accepted22. Of note is that low AOPP levels would predict a larger duration of PD. It seems that AOPP level in serum, not 
CSF, is a prognostic marker of dura-tion and severity of disease, likely because it is a factor contributing 
to neuroinflammation or that blood halogenated proteins contribute to the cascade of events leading to neu-ronal degeneration. 
Our findings also indicate that, in serum and CSF of early-PD patients, there are signs of nitrosative stress affecting proteins. This nitrosyla-tion process was found to be quite selective because 3-nitrotyrosine proteins but not nitroalbumin or nitrosylated amines such as 3-ni-trotyrosine were affected. In this context, the selectivity of tyrosine nitration in many diseases has been highlighted by several authors6,7, and it has been explained by enzymatic catalysis and proximity to sources of nitric oxide synthesis23. This se-lectivity was corroborated after de-
tecting a specific change in N-αSyn, one of the 3-nitrotyrosine proteins. This protein was not found to be en-hanced in the serum, and CSF was 
devoid of its presence, but the profile of nitrosylation of tyrosine residues 
of serum N-αSyn was selectively changed, in early or Hoehn–Yahr 1 
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 increased in Parkinson’s disease. J Neu-rochem. 1989 Feb;52:381–9.5. Witko-Sarsat V, Nguyen-Khoa T, Jun-gers P, Drüeke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant. 1999;14 (Suppl. 1):76–8.6. Ischiropoulos H. Protein tyrosine nitra-tion – An update. Arch Biochem Biophys. 2009 Apr;484(2):117–21.7. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegenera-tion: cause, effect, or association? J Clin Invest. 2003 Jan;111(2):163–9.8. Giasson BI, Duda JE, Murray IV, ChenQ, Souza JM, Hurtig HI, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000 Nov;290(5493):985–9.9. Xu J, Kao SY, Lee FJ, Song W, Jin LW,Yankner BA. Dopamine-dependent neu-rotoxicity of alpha-synuclein: a mecha-nism for selective neurodegeneration in Parkinson disease. Nat Med. 2002 Jun;8(6):600–6.10. Good PF, Hsu A, Werner P, Perl DP,Olanow CW. Protein nitration in Parkin-son’s disease. J Neuropathol Exp Neurol. 1998 Apr;57(4):338–42.11. Qureshi GA, Baig S, Bednar I, Söder-sten P, Forsberg G, Siden A. Increased 
cerebrospinal fluid concentration of ni-trite in Parkinson’s disease. Neuroreport. 1995 Aug;6(12):1642–4. 12. García-Moreno JM, Martín de PablosA, García-Sánchez MI, Méndez-Lucena C, Damas-Hermoso F, Rus M, et al. May se-rum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson’s disease? Anti-oxid Redox Signal. 2013 Apr;18(11): 1296–302.13. Fernandez E, Garcia-Moreno JM, Martin de Pablos A, Chacon J. May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine pro-teins other than nitroalbumin and domi-nant tyrosine-125/136 nitrosylation of 
serum α-synuclein serve for diagnosis of sporadic Parkinson’s disease? Antioxid Redox Signal. 2013 Mar.14. Castellani R, Smith MA, Richey PL,Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 1996 Oct;737(1–2):195–200.
 alterations in function and the onset or propagation of a neurological dis-order is required.
ConclusionOur studies indicate the presence of halogenative and nitrosative stress in serum and, to a lesser extent, cer-
ebrospinal fluid in early PD, char-acterized by excess of AOPP and 3- nitrotyrosine proteins, respec-tively. Metabolism of AOPPs and 3- nitrotyrosine proteins has been as-sociated with several diseases, where blood phagocytes are overstimu-lated. Hence these types of stresses lead to the hypothesis that there is a maintained overstimulation of blood phagocytes in sporadic PD, which leads to excess formation of deriva-tives of hypochlorous acid and nitric oxide. Interestingly, nitrosative stress 
also affects serum N-αSyn, main com-ponent of Lewy bodies, hallmarks of PD. This protein shows an altered 
profile of tyrosine nitrosylation, a change that could represent an im-portant pathogenic mechanism in PD, which  requires further  investigation. 
Abbreviations listAOPP, advanced oxidized protein 
product; CSF, cerebrospinal fluid; HAS, human seroalbumin; HOCL, hy-pochlorous acid; MPO, myeloperoxi-
dase; N-αSyn, nitro-α-synuclein; PD, Parkinson’s disease; ROS/RNS, reac-tive oxygen and nitrogen species
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and 2 patients. This selective change was characterized by  dominant ni-trosylation of Tyr125/136  residues and low nitrosylation of Tyr39 site. In other words, the carboxyl-termi-nus tyrosine sites of the molecule show higher nitrosylation than the amine-terminus one. The ratio between blot intensity of both 
 parameters (N-αSyn-Tyr125/136:N-
αSyn-Tyr39 ratio) was significantly higher in patients with early PD relative to controls and advanced patients. A ratio higher than 1.6 was established as a potential biomarker of early PD. These nitrosative effects were  progressively reduced over time, for unknown reasons.Such a selective change in tyrosine 
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